Literature DB >> 21503880

Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatment.

Meejeon Roh1, Riet van der Meer, Sarki A Abdulkadir.   

Abstract

Polyploidy has been linked to tumorigenicity mainly due to the chromosomal aberrations. Elevated reactive oxygen species (ROS) generation, on the other hand, has also been associated with oncogenic transformation in most cancer cells. However, a possible link between ploidy and ROS is largely unexplored. Here we have examined the role of ROS in the tumorigenicity of polyploid cells. We show that polyploid prostate and mammary epithelial cells contain higher levels of ROS due to their higher mitochondrial contents. ROS levels and mitochondrial mass are also higher in dihydrocytochalasin B (DCB)-induced polyploid cells, suggesting that higher levels of ROS observed in polyploid cell can occur due to cytokinesis failure. Interestingly, polyploid cells were more sensitive to the inhibitory effect of the antioxidant, N-Acetyl-L-cysteine (NAC), than control diploid cells. Treatment of polyploid/diploid cells with NAC led to the selective elimination of polyploid cells over time and abrogated the tumorigenicity of polyploid cells. This effect was partially mediated via the Akt signaling pathway. We next explored a possible role for ROS in promoting chromosomal instability by analyzing the effects of ROS on the mitotic stage of the cell cycle. Enhancing ROS levels by treating cells with hydrogen peroxide delayed not only entry into and but also exit from mitosis. Furthermore, increasing ROS levels significantly increased taxol resistance. Our results indicated that increased ROS in polyploid cells can contribute to tumorigenicity and highlight the therapeutic potential of antioxidants by selectively targeting the tumorigenic polyploid cells and by reversing taxol resistance.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21503880      PMCID: PMC3156849          DOI: 10.1002/jcp.22793

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  59 in total

1.  Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Authors:  Qi Ma; Lucas E Cavallin; Bin Yan; Shoukang Zhu; Elda Margarita Duran; Huili Wang; Laura P Hale; Chunming Dong; Ethel Cesarman; Enrique A Mesri; Pascal J Goldschmidt-Clermont
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-08       Impact factor: 11.205

2.  Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.

Authors:  X Wang; Y-X Zhou; W Qiao; Y Tominaga; M Ouchi; T Ouchi; C-X Deng
Journal:  Oncogene       Date:  2006-05-22       Impact factor: 9.867

3.  Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.

Authors:  Takeshi Fujiwara; Madhavi Bandi; Masayuki Nitta; Elena V Ivanova; Roderick T Bronson; David Pellman
Journal:  Nature       Date:  2005-10-13       Impact factor: 49.962

4.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

5.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

6.  Mitochondrial complex II dysfunction can contribute significantly to genomic instability after exposure to ionizing radiation.

Authors:  Disha Dayal; Sean M Martin; Kjerstin M Owens; Nukhet Aykin-Burns; Yueming Zhu; Amutha Boominathan; Debkumar Pain; Charles L Limoli; Prabhat C Goswami; Frederick E Domann; Douglas R Spitz
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

7.  Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities.

Authors:  Abdülhadi Cihangir Uğuz; Mustafa Naziroğlu; Javier Espino; Ignacio Bejarano; David González; Ana Beatriz Rodríguez; Jose Antonio Pariente
Journal:  J Membr Biol       Date:  2009-11-07       Impact factor: 1.843

8.  Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes.

Authors:  Shannon M Mumenthaler; Patricia Y B Ng; Amanda Hodge; David Bearss; Gregory Berk; Sarath Kanekal; Sanjeev Redkar; Pietro Taverna; David B Agus; Anjali Jain
Journal:  Mol Cancer Ther       Date:  2009-10       Impact factor: 6.261

Review 9.  Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis.

Authors:  Andrew J Holland; Don W Cleveland
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07       Impact factor: 94.444

10.  Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.

Authors:  Dina Dikovskaya; David Schiffmann; Ian P Newton; Abigail Oakley; Karin Kroboth; Owen Sansom; Thomas J Jamieson; Valerie Meniel; Alan Clarke; Inke S Näthke
Journal:  J Cell Biol       Date:  2007-01-15       Impact factor: 10.539

View more
  12 in total

1.  Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer".

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Zhao Lin; Stephanos Pavlides; Diana Whitaker-Menezes; Richard G Pestell; Anthony Howell; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

2.  Metabolism-induced oxidative stress and DNA damage selectively trigger genome instability in polyploid fungal cells.

Authors:  Gregory J Thomson; Claire Hernon; Nicanor Austriaco; Rebecca S Shapiro; Peter Belenky; Richard J Bennett
Journal:  EMBO J       Date:  2019-08-26       Impact factor: 11.598

3.  RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.

Authors:  Monica Logan; Philip D Anderson; Shahrazad T Saab; Omar Hameed; Sarki A Abdulkadir
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

4.  Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer.

Authors:  Alka Choudhary; Brittany Zachek; Robert F Lera; Lauren M Zasadil; Amber Lasek; Ryan A Denu; Hyunjung Kim; Craig Kanugh; Jennifer J Laffin; Josephine M Harter; Kari B Wisinski; Sandeep Saha; Beth A Weaver; Mark E Burkard
Journal:  Mol Cancer Ther       Date:  2015-11-19       Impact factor: 6.261

5.  Polyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence.

Authors:  Grazyna Mosieniak; Malgorzata A Sliwinska; Olga Alster; Anna Strzeszewska; Piotr Sunderland; Malgorzata Piechota; Halina Was; Ewa Sikora
Journal:  Neoplasia       Date:  2015-12       Impact factor: 5.715

6.  Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cells.

Authors:  Ayae Ikawa-Yoshida; Koji Ando; Eiji Oki; Hiroshi Saeki; Ryuichi Kumashiro; Kenji Taketani; Satoshi Ida; Eriko Tokunaga; Hiroyuki Kitao; Masaru Morita; Yoshihiko Maehara
Journal:  Cancer Med       Date:  2013-06-26       Impact factor: 4.452

Review 7.  Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer.

Authors:  Jermaine Coward; Angus Harding
Journal:  Front Oncol       Date:  2014-05-26       Impact factor: 6.244

8.  Whole Chromosome Instability induces senescence and promotes SASP.

Authors:  Grasiella Angelina Andriani; Vinnycius Pereira Almeida; Francesca Faggioli; Maurizio Mauro; Wanxia Li Tsai; Laura Santambrogio; Alexander Maslov; Massimo Gadina; Judith Campisi; Jan Vijg; Cristina Montagna
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

9.  Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation.

Authors:  Le-Xun Wang; Jun-Dan Wang; Jia-Jie Chen; Bing Long; Ling-Ling Liu; Xi-Xiang Tu; Yu Luo; Yuan Hu; Dong-Jun Lin; Gui Lu; Zi-Jie Long; Quentin Liu
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.

Authors:  Mohamed Jemaà; Gwenola Manic; Gwendaline Lledo; Delphine Lissa; Christelle Reynes; Nathalie Morin; Frédéric Chibon; Antonella Sistigu; Maria Castedo; Ilio Vitale; Guido Kroemer; Ariane Abrieu
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.